By Philip Scheltens MD PhD, Serge Gauthier, Philip Scheltens, Jeffrey L. Cummings
content material: Innervation of Senile Plaques: A hyperlink among Amyloid and Neurofibrillary Pathology? B. Delatour, V. Blanchard, L. Pradier, and C. Duyckaerts Vascular components and Alzheimer's affliction, I. Skoog, D. Gustafson, and M. Sjogren The function of White topic Lesions in Dementia, L. Pantoni Subclassification of gentle Cognitive Impairment in study and medical perform, S. Gauthier and J. Touchon Neuropsychiatric features of light Cognitive Impairment, T.J. Hung and J.L. Cummings Cognitive Rehabilitation in light Cognitive Impairment and Prodromal Alzheimer's disorder, M. van der Linden, A.-C. Juillerat, and X. Delbeuck medical Trial layout within the Age of Dementia remedies: demanding situations and possibilities, E. Mohr, C.L. Barclay, R. Anderson, and J. consistent Ethics of analysis in Dementia, J. Karlawish Memantine: A Glutamate Antagonist for remedy of Alzheimer's sickness, R. Smith Doody, B. Winbald, and V. Jelic administration of Comorbidity in Alzheimer's illness, R. Jones dietary Prevention in Alzheimer's sickness, O. Guerin and B. Vellas Index
Read or Download Alzheimer's disease and related disorders annual. / 2004 PDF
Similar geriatrics books
This quantity is to compile famous scientists who research presbycusis from the point of view of complementary disciplines, for a assessment of the present nation of information at the getting older auditory process. Age-related listening to loss (ARHL) is likely one of the most sensible 3 commonest power medical conditions affecting participants elderly sixty five years and older.
The newest addition to the Evidence-Based e-book sequence, Evidence-Based Geriatric drugs presents non-geriatrician clinicians an summary of key subject matters important to the care of the older sufferer. This consultant specializes in the administration of universal difficulties within the aged taking into consideration their existence occasions in addition to therapy of particular stipulations.
This concise, easy-to-read publication summarizes the present medical facts and uncomplicated technology in relation to getting older and the outside, aiding the clinician in addressing dermis difficulties in older dermatologic sufferers. every one bankruptcy specializes in a selected zone within which new wisdom has quickly emerged over the last five years, making sure that the booklet is totally updated.
This encyclopedia brings jointly key confirmed and rising learn findings in geropsychology. it's a accomplished insurance of the total breadth of the sphere, giving readers entry to all significant subareas and illustrating their interconnections with different disciplines. Entries delve deep into key components of geropsychology similar to notion, cognition, medical, organizational, healthiness, social, experimental and neuropsychology.
Extra info for Alzheimer's disease and related disorders annual. / 2004
145. 146. 147. 148. 149. 150. 151. 152. 153. 43 Stern DM, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 2002; 1: 1–15. Yan S, Chen X, Fu J et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer’s disease. Nature 1996; 382:685–691. Vitek MP, Bhattacharya K, Glendening JM et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 1994; 91:4766–4770. Gasparini L, Netzer W, Greengard P, Xu H.
Neuron 1991; 6:729–739. Koh JY, Yang LL, Cotman CW. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990; 533:315– 320. Yankner BA, Dawes LR, Fisher S et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science 1989; 245:417– 420. Neve RL, Robakis NK. Alzheimer’s disease: a re-examination of the amyloid hypothesis. Trends Neurosci 1998; 21:15–19. Lee J, Hong H, Im J et al. The formation of PHF-1 and SMI-31 positive dystrophic neurites in rat hippocampus following acute injection of okadaic acid.
110. 111. 112. 113. 114. 115. 116. 117. 118. 119. 41 Corder E, Saunders A, Strittmatter W et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheirner’s disease in late onset families. Science 1993; 261:921–923. Poirier J, Davignon J, Bouthillier D et al. Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet 1993; 342:697–699. Saunders A, Strittmatter W, Schmechel D et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease.
Alzheimer's disease and related disorders annual. / 2004 by Philip Scheltens MD PhD, Serge Gauthier, Philip Scheltens, Jeffrey L. Cummings